Koide, M <br/><br/>
Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2.  [electronic resource] 

 -  Biochemical and biophysical research communications  May 1999 
 - 97-102 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-291X 
<br/><br/><label>Standard No.: </label>10.1006/bbrc.1999.0715  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Activins<br/>Animals<br/>Bone Development--drug effects<br/>Bone Marrow Cells<br/>Bone Morphogenetic Protein 2<br/>Bone Morphogenetic Proteins--pharmacology<br/>Carrier Proteins--metabolism<br/>Cyclooxygenase 2<br/>Cyclooxygenase 2 Inhibitors<br/>Cyclooxygenase Inhibitors--pharmacology<br/>Gene Expression Regulation, Developmental<br/>Indomethacin--pharmacology<br/>Inhibins--pharmacology<br/>Interleukin-1--pharmacology<br/>Isoenzymes--metabolism<br/>Membrane Glycoproteins--metabolism<br/>Mice<br/>Mice, Inbred Strains<br/>Nitrobenzenes--pharmacology<br/>Osteoclasts--physiology<br/>Prostaglandin-Endoperoxide Synthases--metabolism<br/>RANK Ligand<br/>RNA, Messenger--metabolism<br/>Receptor Activator of Nuclear Factor-kappa B<br/>Sulfonamides--pharmacology<br/>Transforming Growth Factor beta--pharmacology<br/>Up-Regulation--genetics